The AADAP program, which is a part of the United States Fish and Wildlife Service’s Fish and Aquatic Conservation program (USFWS-FAC), is the only program in the U.S. singularly dedicated to obtaining U.S. Food and Drug Administration (FDA) approval of new drugs needed for use in fish culture and fisheries management. AADAP is comprised of four sub-programs: the National Investigational New Animal Drug (INAD), Research, New Animal Drug Approval (NADA), and Outreach programs. Together these programs provide fish culturists and fish health professionals with legal access to a variety of aquaculture drugs currently in the drug approval process, evaluate the safety and efficacy of aquaculture drugs, assist drug sponsors in navigating the new animal drug approval process, and provide fisheries professionals with up-to-date information about existing and pending drug approvals, as well as extensive drug use guidance information. We are a partner-based organization and couldn’t accomplish our mission without the support of our colleagues in the field.
AADAP sends out a monthly news bulletin via an email listserv. These bulletins contain updates about aquaculture drugs currently in the approval process, AADAP programmatic updates, and aquaculture drug use guidance information. If you would like to sign up to receive the AADAP Update, please email Julie Schroeter to be added to our email list.